NEW YORK CITY, NY / ACCESS Newswire / March 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is looking into possible claims for those who bought shares of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who acquired Elanco securities before November 7, 2023, and still own them, are invited to find more details and help with the investigation by visiting the firm's website: bgandg.com/ELAN.
NEW YORK CITY, NY / ACCESS Newswire / March 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is looking into possible claims for those who bought shares of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who acquired Elanco securities before November 7, 2023, and still own them, are invited to find more details and help with the investigation by visiting the firm's website: bgandg.com/ELAN.
NEW YORK CITY, NY / ACCESS Newswire / March 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is looking into possible claims for those who bought shares of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who acquired Elanco securities before November 7, 2023, and still own them, are invited to find more information and help with the investigation by visiting the firm's website: bgandg.com/ELAN.
NEW YORK CITY, NY / ACCESS Newswire / March 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is looking into possible claims for those who bought shares of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who acquired Elanco securities before November 7, 2023, and still own them, are invited to find more details and help with the investigation by visiting the firm's website: bgandg.com/ELAN.
On Tuesday, Elanco Animal Health Incorporated announced its fourth-quarter revenue of $1.02 billion, which is a 1% drop when reported, but shows a 4% growth in organic constant currency. This result surpassed the expected revenue of $1.01 billion.
Elanco Animal Health Incorporated (NYSE:ELAN) will hold its Q4 2024 Earnings Conference Call on February 25, 2024, at 8:00 AM ET. The call will feature company representatives including Tiffany Kanaga, Jeffrey Simmons, and Todd Young, along with participants from various financial institutions. Thank you for joining us for this important update.
Elanco Animal Health Incorporated (ELAN) reported quarterly earnings of $0.14 per share, which is lower than the Zacks Consensus Estimate of $0.15 per share. This is an increase compared to earnings of $0.08 per share from the same period last year.
GREENFIELD, Ind., Feb. 21, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) has announced that it will take part in several upcoming investor conferences.
Pet Protect provides a wide range of supplements that are created by veterinarians and supported by scientific research. The market for pet supplements in the U.S. is expanding as pet owners look for ways to keep their pets healthy.
NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is looking into possible claims for those who bought shares of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who acquired Elanco securities before November 7, 2023, and still own them, are invited to find more details and help with the investigation by visiting the firm's website: bgandg.com/ELAN.